A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

"We were surprised that a higher proportion of life was associated with a higher risk of incident multiple sclerosis in immigrants because multiple sclerosis is often thought to be a predominant ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

A generation ago, a diagnosis of multiple sclerosis often meant a steady decline in quality of life. The autoimmune disease, which affects nearly a million people in the U.S., causes the immune system ...